Replies to post #174243 on Cytodyn Inc (CYDY)

[ClosetInvestor]

“I believe this. Management right now has a clearly presented plan for this year and is making progress.”

You sure about that? Brazil trials we’re supposed to start last month per NP and we’re going to enroll quickly across 45 sites. Last week we were told hopefully by the end of July and that it could 2-3 months to fully enroll.

Yes, super clear plan and progress by management. I’ll believe him more next time if he holds up 2-3 fingers while he says 2-3 months. That’s been trustworthy in the past.

[Northstar42]

The problem with the so called progress the company is making is that it is based on Nader's words not actual deeds. So many times in the past, we have heard reports and touts of impending success only to see them vaporize, never to be mentioned again. Pronouncements and plans always seemed to follow each disappointment with a new set of indications or geographical focus.
In the end, what matters is FDA approval, revenue, and/or support from legitimate financial institutions. Honestly, I had been a true believer in the Nader pipeline of hype for many years, but I no longer can accept what is happening under the current management. Shareholders should settle for nothing less than the responsible stewardship of Leronlimab.